跳至主要内容
临床试验/TCTR20230301004
TCTR20230301004已完成2 期

The efficacy of intraoperative parecoxib with paracetamol for reducing opioid consumption in patient undergoing breast cancer surgery under general anesthesia: A prospective randomized controlled trial

FACULTY OF MEDICINE RESEARCH GRANT KHON KAEN UNIVERSITY0 个研究点目标入组 60 人开始时间: 2023年3月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

A perioperative combination of intravenous Parecoxib and Paracetamol significantly reduced postoperative morphine consumption during 24 hours and improved the quality of life postoperatively, although without statistically significance

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
Female

入选标准

  • female age 18-65 year
  • ASA classification 1-3
  • Patients scheduled for elective breast surgery under general anesthesia at operating room, Srinagarind hospital

排除标准

  • Patients with hypersensitivity or contraindication to the study drugs.
  • allergy for sulfamethoxazole
  • History of opioid or steroid (Dexamethasone,Hydrocortisone) used.
  • Psychologic problems
  • Operation change
  • Refuse to participate

研究者

发起方
FACULTY OF MEDICINE RESEARCH GRANT KHON KAEN UNIVERSITY

相似试验